For Guidant, J&amp;J&#39;s resources sealed the deal
335586
After lengthy talks and stiff negotiations over price, the decision by Guidant executives to sell the company for $25.4 billion came down to the attractiveness of Johnson &amp; Johnson&#39;s deep resources.
263676
Guidant Corp. (GDT.N: Quote, Profile, Research) said on Thursday it has resolved manufacturing and design problems that caused tiny fractures in its experimental
199086
Johnson & Johnson has agreed to  buy Guidant Corp. for $25.4 billion in cash and stock, the  companies said on Wednesday, giving the healthcare products  maker a foothold in the fast-growing market for implantable  devices that regulate heartbeats.
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.
336391
U.S. blue chips closed slightly higher  on Thursday, helped by Johnson & Johnson Inc.'s JNJ.N $25  billion deal to buy Guidant Corp. GDT.N, but the broader  market fell, with Goldman Sachs Group Inc. GS.N dragging the  S&P 500 lower after posting quarterly revenues that  disappointed Wall Street.
595193
Johnson &amp; Johnson (JNJ:NYSE - news - research) reportedly is negotiating to buy Guidant (GDT:NYSE - news - research) for $24 billion, a transaction that would unite two big manufacturers of coronary devices.
110146
Johnson & Johnson said Thursday that its Cordis unit has resolved its issues with the F.D.A., clearing the way for the introduction of new cardiovascular devices.
497700
NEW YORK -- Johnson &amp; Johnson, the New Jersey-based drug and health care products company, is reportedly in advanced negotiations to buy Guidant Corp.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
312826
Johnson &amp; Johnson announced that it will acquire Guidant Corp., one of the world&#39;s top makers of cardiac devices, for $25.4 billion US.
360773
Johnson &amp; Johnson, whose board is meeting today, is close to agreeing to pay $24 billion for Guidant Corp., the world&#39;s second-biggest maker of heart-rhythm devices, people familiar with the matter said.
48544
New Brunswick (dpa) -Johnson &amp; JOhnson, one of the world&#39;s largest pharmaceutical and medical devices producers, is buying Guidant Corporation for 25.4 billion dollars, Johnson &amp; JOhnson said Thursday.